These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 50663)

  • 1. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the thyrotropin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy].
    Otter R; Wiersinga WM; Peeters HF; Bleeker GM; Touber JL
    Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2189-93. PubMed ID: 6817147
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperthyroidism and excessive thyrotropin secretion.
    Emerson CH; Utiger RD
    N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
    [No Abstract]   [Full Text] [Related]  

  • 5. [TRH stimulation test. II. Evaluation of thyroid response].
    Dussault JH; Coulombe P
    Union Med Can; 1973 Dec; 102(12):2485-9. PubMed ID: 4204002
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid function tests.
    Sterling K
    Adv Intern Med; 1972; 18():345-62. PubMed ID: 4126139
    [No Abstract]   [Full Text] [Related]  

  • 7. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid-stimulating immunoglobulins and the control of thyroid function.
    Clague R; Mukhtar ED; Pyle GA; Nutt J; Clark F; Scott M; Evered D; Smith BR; Hall R
    J Clin Endocrinol Metab; 1976 Sep; 43(3):550-6. PubMed ID: 821961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indicators of the thyroid status in obesity depending on the types of the hypothalamo-hypophyseal system reaction].
    Spesivtseva VG; Alimova GA; Zubovskiĭ GA; Leonova LN
    Ter Arkh; 1982; 54(10):46-9. PubMed ID: 6817431
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs.
    Ormston BJ; Alexander L; Evered DC; Clark F; Bird T; Appleton D; Hall R
    Clin Endocrinol (Oxf); 1973 Oct; 2(4):369-76. PubMed ID: 4128973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Etiology and diagnosis of Basedow's disease].
    Nakai T
    Rinsho Byori; 1984 Jan; Spec No 58():120-9. PubMed ID: 6088843
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosing thyroid disease by selected laboratory tests.
    Wahner HW
    Geriatrics; 1974 Jan; 29(1):83-6 passim. PubMed ID: 4202655
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the triiodothyronine suppression test with serum T4 and thyroid 131I uptake as indexes in judging the prognosis of Graves' disease].
    Luo GC
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):154-6, 189. PubMed ID: 3094869
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of thyroid function.
    Rosenberg IN
    N Engl J Med; 1972 Apr; 286(17):924-7. PubMed ID: 4111176
    [No Abstract]   [Full Text] [Related]  

  • 15. [Improved evaluation criteria of autonomous thyroid adenoma: triiodothyronine concentration in serum, functional definition through TRH test].
    Wenzel KW; Meinhold H; Schleusener H; Botsch H
    Dtsch Med Wochenschr; 1974 Jul; 99(27):1465-73. PubMed ID: 4135676
    [No Abstract]   [Full Text] [Related]  

  • 16. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
    Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
    J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of T3 suppression and TRH stimulation tests in the diagnosis of ophthalmic Graves' disease].
    Tao Y; Song GX
    Zhonghua Yi Xue Za Zhi; 1987 Dec; 67(12):665-7. PubMed ID: 3130158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypothalamo-hypophyseal-thyroid axis in the aged].
    Mollerach F; Degrossi OJ; Scornavachi JC; Carneiro L; Almeida CA; de Casas OI; Cima ME
    Medicina (B Aires); 1978; 38(3):276-80. PubMed ID: 99630
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thyroid gland function test in the child].
    Vallee G
    Arch Fr Pediatr; 1976 Dec; 33(10):997-1002. PubMed ID: 828032
    [No Abstract]   [Full Text] [Related]  

  • 20. [TRH stimulation test. II. Evaluation of thyroid response].
    Dussault JH; Coulombe P
    Union Med Can; 1973 Dec; 102(12):2480-5. PubMed ID: 4204001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.